Create Alert
Watchlist

Remus Pharmaceuticals

₹695.05
-32.15 (4.42%) 1D
NSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All

Performance

Open
725.00
Prev. Close
727.20
Volume
2,400
Total traded value
0.17 Cr
Upper Circuit
834.05
Lower Circuit
556.05

Fundamentals

Market Cap₹819Cr
ROE10.92%
P/E Ratio(TTM)21.32
EPS(TTM)32.60
P/B Ratio3.20
Dividend Yield0.11%
Industry P/E33.19
Book Value217.13
Debt to Equity0.05
Face Value10
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Remus Pharmaceuticals

Remus Pharmaceuticals Limited operates in the global pharmaceutical industry, focusing on marketing and distributing a variety of finished drug formulations. Its mission is to provide quality healthcare solutions, navigating the dynamic challenges of the global healthcare sector with a firm commitment to innovation. The company sources a wide range of its pharmaceutical products that are manufactured on a contract basis or through loan license agreements. It also offers technical consultancy services, assisting international distributors with preparing reports and dossiers for product registration in their countries. A key strategic focus includes expanding market reach, optimising distribution networks, and enhancing its product offerings to ensure sustainable growth. This strategy resulted in a remarkable 367.55% increase in total revenue during the 2024 fiscal year compared to the prior year.;
Parent OrganisationRemus Pharmaceuticals
Managing DirectorMr. Arpit Deepakkumar Shah
NSE SymbolREMUS

Shareholding Pattern

Jun '24
Sep '24
Mar '25
Jul '25
Sep '25
Promoters
70.91%
Retail And Others
24.08%
Foreign Institutions
5.02%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Biocon
NA
(0.00%)
69.54
Anthem Biosciences
NA
(0.00%)
69.11
Onesource Specialty Pharma
NA
(0.00%)
467.41
Advanced Enzyme Technologies
NA
(0.00%)
23.53